ADVISORY, Nov. 4, 2011 (GLOBE NEWSWIRE) -- What: NPS Pharmaceuticals (Nasdaq:NPSP) a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options, will visit the NASDAQ MarketSite in New York City's Times Square.
